Celecoxib

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
40023
Multicentre, double-blind, placebo-controlled randomised phase III study of adjuvant therapy with celecoxib in combination with chemotherapy in patients with curatively resected stage III colon cancer (PETACC-5).
40015
Irinotecan combined with infusional 5-FU/Folinic acid or Capecitabine and the role of Celecoxib in patients with metastatic colorectal cancer

Back to Protocol section